Tagged Content

Tags > Medication Updates
Year: Medication:  Abilify (aripiprazole) Addyi Antipsychotics Aripiprazole Aristada Belsomra Brintellix Buprenorphine and naloxone Probuphine Clozapine Chantix and Zyban Cymbalta Daytrana Diazepam Effexor Farxiga Fentanyl and Opioids Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine Olanzapine/Zyprexa Opioids Opioids and Benzodiazepines Rexulti Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vraylar Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2016 FDA revises risk of mental health side effects of Chantix and Zyban After a large clinical trial, the revised risk of mental health side effects with Chantix (varenicline) and Zyban (bupropion) was found to be lower than previously throught. FDA issues strongest warning of risks when combining opioid pain or cough medicines with benzodiazepines The review found that combined use of these drugs results in serious side effects, including difficulty breathing and death. Counterfeit pills fueling fentanyl and opioid crisis, DEA reports Counterfeit prescription pills containing deadly amounts of fentanyl (a synthetic opioid) have entered the US drug market.



View all tags
View RSS XML
The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Celebrate Excellence with the APNA Annual Awards
Recognize a colleague for their commitment to psychiatric-mental health nursing with an APNA Annual Award by April 18.  |  View

Take Action: #StandforMentalHealth
Share the new APNA position paper on proactive health care policies to ease the burden of mental illness and substance use disorders.  |  View

Now Accepting Applications: APNA Board of Directors Scholarship
Help us find up to 30 exceptional graduate and undergraduate/pre-licensure nursing students to receive the 2017 APNA Board of Directors Student Scholarship!  |  View

APNA 2017 Call for Nominations
Submit a nomination for the APNA Board of Directors and 2018 Nominating Committee by April 17, 2017.   |  View

Register Now for the APNA 15th Annual Clinical Psychopharmacology Institute
CPI, to be held June 8-11 in Baltimore, Maryland, will offer up to 21.5 continuing education contact hours in psychopharmacology.  |  View

Free CE: February 14 - March 15
Nearly all sessions in the APNA eLearning Center will be free of cost for members beginning February 14.  |  View

Buprenorphine Waiver Training for APRNs
APNA and PCSS-MAT have partnered to provide no cost MAT waiver training to nurses and physician assistants.  |  View

APNA Research Grants: Now Accepting Proposals
APNA is seeking research proposals from new nurse researchers to be awarded funding between $1,000 and $10,000.   |  View

APNA 31st Annual Conference Call for Abstracts Now Open
Submit an abstract for consideration as a presentation at this fall's conference in Phoenix. |  View

Tobacco Dependence Resources
Updated expert-vetted online resources from the Tobacco Dependence Branch of the APNA Addictions Council.  |  View

2016 APNA Activity Report Available Now
This report speaks to key APNA activities from the past year. |  View

New Education to Address Opioid Use Crisis
The no cost educational sessions were designed to support nurses in all fields as they address the opioid use epidemic. |  View

New Resources on Violence Prevention
New toolkit and position paper to support psychiatric-mental health nurses in their violence prevention efforts. |  View